| Hannah Salefsky, PA-C | |
|
6727 Parker Farm Dr, Wilmington, NC 28405-3176 | |
| (910) 772-0370 | |
| (910) 256-5985 |
| Full Name | Hannah Salefsky |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 6727 Parker Farm Dr, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013551886 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0010-10575 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wilmington Health Pllc | 6103722509 | 283 |
News Archive
A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead to new treatments to fight this deadly disease.
The Zilver PTX Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration's (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee, Cook Medical announced today.
The first laser treatments used to treat skin conditions such as benign vascular birthmarks and port-wine stains were developed more than 40 years ago. Since then, clinicians and dermatologists have seen a rise in demand for minimally invasive laser-based treatments, including tattoo removal.
Life's genetic code has only ever contained four natural bases. These bases pair up to form two "base pairs"—the rungs of the DNA ladder—and they have simply been rearranged to create bacteria and butterflies, penguins and people. Four bases make up all life as we know it.
KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, today announced the initiation of two pivotal U.S. Phase III trials of ATX-101, a first-in-class injectable drug under clinical investigation for the reduction of submental (under the chin) fat.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hannah Salefsky, PA-C 1202 Medical Center Dr, Wilmington, NC 28401-7307 Ph: (910) 617-6705 | Hannah Salefsky, PA-C 6727 Parker Farm Dr, Wilmington, NC 28405-3176 Ph: (910) 772-0370 |
News Archive
A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead to new treatments to fight this deadly disease.
The Zilver PTX Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration's (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee, Cook Medical announced today.
The first laser treatments used to treat skin conditions such as benign vascular birthmarks and port-wine stains were developed more than 40 years ago. Since then, clinicians and dermatologists have seen a rise in demand for minimally invasive laser-based treatments, including tattoo removal.
Life's genetic code has only ever contained four natural bases. These bases pair up to form two "base pairs"—the rungs of the DNA ladder—and they have simply been rearranged to create bacteria and butterflies, penguins and people. Four bases make up all life as we know it.
KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, today announced the initiation of two pivotal U.S. Phase III trials of ATX-101, a first-in-class injectable drug under clinical investigation for the reduction of submental (under the chin) fat.
› Verified 7 days ago
Robin Elizabeth Jendrazak, OPA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2716 Ashton Dr, Wilmington, NC 28412 Phone: 910-332-3800 Fax: 910-332-3833 | |
Crystal Dawn Hill, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2421 Silver Stream Ln, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-251-8824 | |
Rya Elisabeth Lawrence, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-791-0075 Fax: 910-791-9674 | |
Talia Francesca Marie Mcdonough, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1988 S 16th St, Wilmington, NC 28401 Phone: 910-662-8440 Fax: 910-795-4826 | |
Mr. Grayson Brent Mayberry, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1415 Physicians Dr, Wilmington, NC 28401 Phone: 910-662-9500 Fax: 910-662-9501 | |
Chase Jonathan Whelan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2208 S 17th St Ste 201, Wilmington, NC 28401 Phone: 910-763-3333 |